Showing results (431-440 of 478) with videos related to

Sort By:
Pageof 48
JACC. Cardiovascular Interventions|March 20, 2010
Recommendations for successful training on methods of delivery of biologics for cardiac regeneration: a report of the International Society for Cardiovascular Translational ResearchNabil Dib, Philippe Menasche, Jozef J Bartunek, et al.
The American Journal of Cardiology|May 2, 2016
Impact of Anemia on Platelet Reactivity and Ischemic and Bleeding Risk: From the Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents StudyGennaro Giustino, Ajay J Kirtane, Usman Baber, et al.
Circulation. Cardiovascular Interventions|July 28, 2023
EXACT Trial: Results of the Phase 1 Dose-Escalation StudyThomas J Povsic, Timothy D Henry, Jay H Traverse, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 14, 2019
Impact of high on-treatment platelet reactivity on outcomes following PCI in patients on hemodialysis: An ADAPT-DES substudyGeoffrey A Rubin, Ajay J Kirtane, Shmuel Chen, et al.
The Canadian Journal of Cardiology|May 11, 2021
The Placebo Effect on Symptoms, Quality of Life, and Functional Outcomes in Patients With Angina Pectoris: A Meta-analysis of Randomized Placebo-Controlled TrialsGuglielmo Gallone, Luca Baldetti, Filippo Angelini, et al.
Circulation|November 16, 2017
Impact of Regionalization of ST-Segment-Elevation Myocardial Infarction Care on Treatment Times and Outcomes for Emergency Medical Services-Transported Patients Presenting to Hospitals With Percutaneous Coronary Intervention: Mission: Lifeline Accelerator-2James G Jollis, Hussein R Al-Khalidi, Mayme L Roettig, et al.
Circulation Research|December 7, 2017
TIME Trial: Effect of Timing of Stem Cell Delivery Following ST-Elevation Myocardial Infarction on the Recovery of Global and Regional Left Ventricular Function: Final 2-Year AnalysisJay H Traverse, Timothy D Henry, Carl J Pepine, et al.
Lancet (London, England)|September 6, 2013
Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational studyRoxana Mehran, Usman Baber, Philippe Gabriel Steg, et al.
Circulation. Cardiovascular Interventions|March 29, 2020
Bleeding Risk, Dual Antiplatelet Therapy Cessation, and Adverse Events After Percutaneous Coronary Intervention: The PARIS RegistrySabato Sorrentino, Samantha Sartori, Usman Baber, et al.
The American Journal of Cardiology|July 30, 2017
Quantifying Ischemic Risk After Percutaneous Coronary Intervention Attributable to High Platelet Reactivity on Clopidogrel (From the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents Study)Björn Redfors, Ori Ben-Yehuda, Sheng-Hsuan Lin, et al.
Pageof 48